Publication | Open Access

The release of Doxorubicin from liposomes monitored by MRI and triggered by a combination of US stimuli led to a complete tumor regression in a breast cancer mouse model

Breast OncologyUs StimuliMedicineExtracellular MicrovesiclesBreast CancerTumor TargetingAnti-cancer AgentComplete Tumor RegressionPharmacologyCell BiologyTumor MicroenvironmentTumor Biology